Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tyra Biosciences, Inc. before investing.

In this article, we go over a few key elements for understanding Tyra Biosciences, Inc.’s stock price such as:

• Tyra Biosciences, Inc.’s current stock price and volume
• Why Tyra Biosciences, Inc.’s stock price changed recently
• Upgrades and downgrades for TYRA from analysts
• TYRA’s stock price momentum as measured by its relative strength

About Tyra Biosciences, Inc. (TYRA)

Before we jump into Tyra Biosciences, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Want to learn more about Tyra Biosciences, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Tyra Biosciences, Inc..

Tyra Biosciences, Inc.’s Stock Price as of Market Close

As of December 02, 2025, 4:00 PM, CST, Tyra Biosciences, Inc.’s stock price was $20.920.

Tyra Biosciences, Inc. is up 0.53% from its previous closing price of $20.810.

During the last market session, Tyra Biosciences, Inc.’s stock traded between $20.075 and $21.170. Currently, there are approximately 59.67 million shares outstanding for Tyra Biosciences, Inc..

Tyra Biosciences, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Tyra Biosciences, Inc. Stock Price History

Tyra Biosciences, Inc.’s (TYRA) price is currently down 7.27% so far this month.

During the month of December, Tyra Biosciences, Inc.’s stock price has reached a high of $21.980 and a low of $20.075.

Over the last year, Tyra Biosciences, Inc. has hit prices as high as $22.825 and as low as $6.420. Year to date, Tyra Biosciences, Inc.’s stock is up 50.5%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Tyra Biosciences, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of December 01, 2025,, no analysts have changed their rating of Tyra Biosciences, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Tyra Biosciences, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Tyra Biosciences, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Tyra Biosciences, Inc. (TYRA) by visiting AAII Stock Evaluator.

Relative Price Strength of Tyra Biosciences, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 01, 2025, Tyra Biosciences, Inc. has a weighted four-quarter relative price strength of 23.18%, which translates to a Momentum Score of 92 and is considered to be Very Strong.

Want to learn more about how Tyra Biosciences, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Tyra Biosciences, Inc. Stock Price: Bottom Line

As of December 2, 2025, Tyra Biosciences, Inc.’s stock price is $20.920, which is up 0.53% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Tyra Biosciences, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.